Literature DB >> 2509274

Evolution of variable and constant domains and joining segments of rearranging immunoglobulins.

J J Marchalonis1, S F Schluter.   

Abstract

The rearranging immunoglobulins (Igs) are a family of recognition and defense proteins found in all vertebrate classes. These proteins consist of two types of polypeptide chains; each of these contains a variable (V) domain, a joining (J) segment, and a constant (C) region, which can itself consist of one to four domains. The distinction between light and heavy chains is an ancient one phylogenetically that is reflected in the structures of V, J, and C regions. Despite the early emergence of these genetic elements, conservatism is apparent in the peptide structures encoded by V, J, and C exons. C regions of heavy chains did not evolve as single units; rather the individual domains show their own clustering patterns, which apparently are independent of heavy-chain designation or species. C-region domains of light chains and the T cell receptor beta chain are similar to one another and to the most carboxyl-terminal domain of heavy chains. Comparison of the light chains of sharks, bullfrogs, chickens, and mammals indicated that a phylogenetic distinction can be made between kappa and lambda light chains. V and J segments of the rearranging T cell receptors alpha, gamma, and delta are homologous to the corresponding segments of Igs, but their C regions form a group that is markedly distinct from those of conventional Igs and Tcr beta.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2509274     DOI: 10.1096/fasebj.3.13.2509274

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  9 in total

1.  Antigenic mapping of a human lambda light chain: correlation with three dimensional structure.

Authors:  J J Marchalonis; F Dedeoglu; H Kaymaz; S F Schluter; A B Edmundson
Journal:  J Protein Chem       Date:  1992-04

2.  Complete sequence of a cDNA clone specifying sandbar shark immunoglobulin light chain: gene organization and implications for the evolution of light chains.

Authors:  V S Hohman; S F Schluter; J J Marchalonis
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

3.  Identification of two principal amyloid-driving segments in variable domains of Ig light chains in systemic light-chain amyloidosis.

Authors:  Boris Brumshtein; Shannon R Esswein; Michael R Sawaya; Gregory Rosenberg; Alan T Ly; Meytal Landau; David S Eisenberg
Journal:  J Biol Chem       Date:  2018-10-24       Impact factor: 5.157

4.  Physical and epitope analysis of a recombinant human T-cell receptor V alpha/V beta construct support the similarity to immunoglobulin.

Authors:  D F Lake; S Helgerson; W J Landsperger; J J Marchalonis
Journal:  J Protein Chem       Date:  1997-05

5.  Formation of amyloid fibers by monomeric light chain variable domains.

Authors:  Boris Brumshtein; Shannon R Esswein; Meytal Landau; Christopher M Ryan; Julian P Whitelegge; Martin L Phillips; Duilio Cascio; Michael R Sawaya; David S Eisenberg
Journal:  J Biol Chem       Date:  2014-08-19       Impact factor: 5.157

6.  Human autoantibodies reactive with synthetic autoantigens from T-cell receptor beta chain.

Authors:  J J Marchalonis; H Kaymaz; F Dedeoglu; S F Schluter; D E Yocum; A B Edmundson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

Review 7.  Intermediate- and high-risk melanoma.

Authors:  Sanjiv S Agarwala
Journal:  Curr Treat Options Oncol       Date:  2002-06

8.  Comparative genomic analysis and evolution of the T cell receptor loci in the opossum Monodelphis domestica.

Authors:  Zuly E Parra; Michelle L Baker; Jennifer Hathaway; April M Lopez; Jonathan Trujillo; Alana Sharp; Robert D Miller
Journal:  BMC Genomics       Date:  2008-02-29       Impact factor: 3.969

9.  Inhibition by small-molecule ligands of formation of amyloid fibrils of an immunoglobulin light chain variable domain.

Authors:  Boris Brumshtein; Shannon R Esswein; Lukasz Salwinski; Martin L Phillips; Alan T Ly; Duilio Cascio; Michael R Sawaya; David S Eisenberg
Journal:  Elife       Date:  2015-11-18       Impact factor: 8.140

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.